A citation-based method for searching scientific literature

R F M Vermeulen, M van Beurden, C M Korse, G G Kenter. Climacteric 2017
Times Cited: 22







List of co-cited articles
161 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
994
50

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
872
31

The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
A Finch, K A Metcalfe, J K Chiang, L Elit, J McLaughlin, C Springate, R Demsky, J Murphy, B Rosen, S A Narod. Gynecol Oncol 2011
129
31

Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study.
Ravi F M Vermeulen, Marc van Beurden, Jacobien M Kieffer, Eveline M A Bleiker, Heiddis B Valdimarsdottir, Leon F A G Massuger, Marian J E Mourits, Katja N Gaarenstroom, Eleonora B L van Dorst, Hans W H M van der Putten,[...]. Eur J Cancer 2017
24
31


Risk factors for sexual dysfunction in BRCA mutation carriers after risk-reducing salpingo-oophorectomy.
Jessica L Chan, Suneeta Senapati, Lauren N C Johnson, Laura DiGiovanni, Chan Voong, Samantha F Butts, Susan M Domchek. Menopause 2019
12
50

Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
Joanne Kotsopoulos, Jacek Gronwald, Beth Y Karlan, Tomasz Huzarski, Nadine Tung, Pal Moller, Susan Armel, Henry T Lynch, Leigha Senter, Andrea Eisen,[...]. JAMA Oncol 2018
69
22

Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.
Marline G Harmsen, Marieke Arts-de Jong, Nicoline Hoogerbrugge, Angela H E M Maas, Judith B Prins, Johan Bulten, Steven Teerenstra, Eddy M M Adang, Jurgen M J Piek, Helena C van Doorn,[...]. BMC Cancer 2015
68
22

Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers: A single-center experience.
M G Harmsen, M Arts-de Jong, K Horstik, P Manders, L F A G Massuger, R P M G Hermens, N Hoogerbrugge, G H Woldringh, J A de Hullu. Gynecol Oncol 2016
16
31

The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Joanna B Madalinska, Marc van Beurden, Eveline M A Bleiker, Heiddis B Valdimarsdottir, Judith Hollenstein, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2006
145
22

Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits.
Sushmita Gordhandas, Barbara M Norquist, Kathryn P Pennington, Rachel L Yung, Mary B Laya, Elizabeth M Swisher. Gynecol Oncol 2019
39
22

Non-hormonal treatments for menopausal symptoms.
Martha Hickey, Rebecca A Szabo, Myra S Hunter. BMJ 2017
27
18

Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Theresa Wagner, Henry T Lynch, Judy E Garber, Mary B Daly, Claudine Isaacs, Olufunmilayo I Olopade, Susan L Neuhausen, Laura van 't Veer,[...]. J Clin Oncol 2005
270
18

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
362
18



Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
Elizabeth Hall, Amy Finch, Michelle Jacobson, Barry Rosen, Kelly Metcalfe, Ping Sun, Steven A Narod, Joanne Kotsopoulos. Gynecol Oncol 2019
21
19

Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history.
Jennifer L Marino, Christobel M Saunders, Laura I Emery, Helena Green, Dorota A Doherty, Martha Hickey. Menopause 2014
40
13

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006
402
13

Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy.
Nora Johansen, Astrid H Liavaag, Ole-Erik Iversen, Anne Dørum, Tonje Braaten, Trond M Michelsen. Acta Obstet Gynecol Scand 2017
10
30

Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer.
Ingrid E Fakkert, Elske Marije Abma, Iris G Westrik, Joop D Lefrandt, Bruce H R Wolffenbuttel, Jan C Oosterwijk, Riemer H J A Slart, Eveline van der Veer, Geertruida H de Bock, Marian J E Mourits. Eur J Cancer 2015
24
13

Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction.
B A M Heemskerk-Gerritsen, C Seynaeve, C J van Asperen, M G E M Ausems, J M Collée, H C van Doorn, E B Gomez Garcia, C M Kets, F E van Leeuwen, H E J Meijers-Heijboer,[...]. J Natl Cancer Inst 2015
122
13

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Joanna B Madalinska, Judith Hollenstein, Eveline Bleiker, Marc van Beurden, Heiddis B Valdimarsdottir, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2005
169
13

Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Kelly Metcalfe, Henry T Lynch, William D Foulkes, Nadine Tung, Charmaine Kim-Sing, Olufunmilayo I Olopade, Andrea Eisen, Barry Rosen, Carrie Snyder, Shelley Gershman,[...]. JAMA Oncol 2015
68
13

The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review.
Tasneem Siyam, Sue Ross, Sandra Campbell, Dean T Eurich, Nesé Yuksel. BMC Womens Health 2017
12
25

Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations.
Denise R Nebgen, Jean Hurteau, Laura L Holman, Andrea Bradford, Mark F Munsell, Beth R Soletsky, Charlotte C Sun, Gary B Chisholm, Karen H Lu. Gynecol Oncol 2018
33
13

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
365
13

A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing.
Marline G Harmsen, Miranda P Steenbeek, Nicoline Hoogerbrugge, Helena C van Doorn, Katja N Gaarenstroom, M Caroline Vos, Leon F A G Massuger, Joanne A de Hullu, Rosella P M G Hermens. Health Expect 2018
12
25

Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy.
A Stuursma, C M G van Driel, N J Wessels, G H de Bock, M J E Mourits. Maturitas 2018
14
21

Review Article: Sexuality and Risk-Reducing Salpingo-oophorectomy.
Paige E Tucker, Paul A Cohen. Int J Gynecol Cancer 2017
9
33

Cancer Risks for PMS2-Associated Lynch Syndrome.
Sanne W Ten Broeke, Heleen M van der Klift, Carli M J Tops, Stefan Aretz, Inge Bernstein, Daniel D Buchanan, Albert de la Chapelle, Gabriel Capella, Mark Clendenning, Christoph Engel,[...]. J Clin Oncol 2018
86
13



Exercise for vasomotor menopausal symptoms.
Amanda Daley, Helen Stokes-Lampard, Adèle Thomas, Christine MacArthur. Cochrane Database Syst Rev 2014
60
9

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
Peter Kenemans, Nigel J Bundred, Jean-Michel Foidart, Ernst Kubista, Bo von Schoultz, Piero Sismondi, Rena Vassilopoulou-Sellin, Cheng Har Yip, Jan Egberts, Mirjam Mol-Arts,[...]. Lancet Oncol 2009
165
9


Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial.
Mia Fahlén, Tommy Fornander, Hemming Johansson, Ulla Johansson, Lars-Erik Rutqvist, Nils Wilking, Eva von Schoultz. Eur J Cancer 2013
60
9

Long-term hormone therapy for perimenopausal and postmenopausal women.
Jane Marjoribanks, Cindy Farquhar, Helen Roberts, Anne Lethaby, Jasmine Lee. Cochrane Database Syst Rev 2017
177
9


Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors.
Gary Elkins, Joel Marcus, Vered Stearns, Michelle Perfect, M Hasan Rajab, Christopher Ruud, Lynne Palamara, Timothy Keith. J Clin Oncol 2008
112
9


Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial.
Michelle E Melisko, Mindy E Goldman, Jimmy Hwang, Amy De Luca, Sally Fang, Laura J Esserman, Amy J Chien, John W Park, Hope S Rugo. JAMA Oncol 2017
75
9

Menopausal hormone therapy in cancer survivors: A narrative review of the literature.
Carol L Kuhle, Ekta Kapoor, Richa Sood, Jacqueline M Thielen, Aminah Jatoi, Stephanie S Faubion. Maturitas 2016
18
11

Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters.
JoAnn V Pinkerton, Lucy Abraham, Andrew G Bushmakin, Joseph C Cappelleri, Barry S Komm. Menopause 2016
29
9

Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions.
Claire Johns, Susan M Seav, Sally A Dominick, Jessica R Gorman, Hongying Li, Loki Natarajan, Jun James Mao, H Irene Su. Breast Cancer Res Treat 2016
43
9

Hip fracture incidence in relation to age, menopausal status, and age at menopause: prospective analysis.
Emily Banks, Gillian K Reeves, Valerie Beral, Angela Balkwill, Bette Liu, Andrew Roddam. PLoS Med 2009
47
9

Local oestrogen for vaginal atrophy in postmenopausal women.
Anne Lethaby, Reuben Olugbenga Ayeleke, Helen Roberts. Cochrane Database Syst Rev 2016
107
9

Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.
D Gareth R Evans, Sarah L Ingham, Andrew Baildam, Gary L Ross, Fiona Lalloo, Iain Buchan, Anthony Howell. Breast Cancer Res Treat 2013
96
9

Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
Joanna B Madalinska, Marc van Beurden, Eveline M A Bleiker, Heiddis B Valdimarsdottir, Lottie Lubsen-Brandsma, Leon F Massuger, Marian J E Mourits, Katja N Gaarenstroom, Eleonora B L van Dorst, Hans van der Putten,[...]. J Clin Oncol 2007
55
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.